ArticleTherapeutic advances in hematology2020

Low dose continuous lenalidomide in heavily pretreated patients with relapsed or refractory classical Hodgkin lymphoma: a retrospective case series.

Helen Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.